← Evidence map

GuidelineGynecologic oncology2009

American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Sarah TeminPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 19716939